News of the joint venture comes months after AstraZeneca vowed to spend $15 billion in China by the end of the decade.
AstraZeneca partners with CSPC to build Chinese biologics manufacturing plant
Nick Paul Taylor
News of the joint venture comes months after AstraZeneca vowed to spend $15 billion in China by the end of the decade.